Literature DB >> 29157395

Pediatric Multiple Sclerosis: From Recognition to Practical Clinical Management.

Cynthia X Wang1, Benjamin M Greenberg2.   

Abstract

Pediatric-onset multiple sclerosis (MS) is a rare but increasingly recognized condition that both parallels and diverges from adult-onset MS. Exposure to key risk determinants for MS disease pathogenesis may occur during childhood. The diagnosis of pediatric MS can be challenging due to potential for atypical presentations and a broad differential diagnosis. MS disease-modifying therapies have not been rigorously studied in children and raise difficult questions on how to manage a chronic inflammatory neurologic disease in a population of patients with developing central nervous and immune systems.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Children; Demyelination; Diagnosis; Multiple sclerosis; Treatment

Mesh:

Year:  2018        PMID: 29157395     DOI: 10.1016/j.ncl.2017.08.005

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  2 in total

1.  Fingolimod as first-line treatment in pediatric-onset multiple sclerosis: a case report.

Authors:  Marco Capobianco; Antonio Bertolotto; Simona Malucchi
Journal:  Neurol Sci       Date:  2021-03-12       Impact factor: 3.307

Review 2.  Current Advances in Pediatric Onset Multiple Sclerosis.

Authors:  Kristen S Fisher; Fernando X Cuascut; Victor M Rivera; George J Hutton
Journal:  Biomedicines       Date:  2020-03-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.